New Two-Step therapy aims to stop chronic kidney transplant rejection
Disease control
Not yet recruiting
This study tests a new treatment for chronic active antibody-mediated rejection (caABMR) in kidney transplant recipients. Patients receive a single injection of a CD38 monoclonal antibody to deplete harmful immune cells, followed by long-term azathioprine pills to maintain contro…
Phase: NA • Sponsor: wujianyong • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC